0001567619-19-019033.txt : 20191002 0001567619-19-019033.hdr.sgml : 20191002 20191002141109 ACCESSION NUMBER: 0001567619-19-019033 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191002 DATE AS OF CHANGE: 20191002 EFFECTIVENESS DATE: 20191002 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Psy Therapeutics, Inc. CENTRAL INDEX KEY: 0001788222 IRS NUMBER: 464703014 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-350167 FILM NUMBER: 191131598 BUSINESS ADDRESS: STREET 1: 28 ATLANTIC AVE, SUITE 129 CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: (617) 723-5429 MAIL ADDRESS: STREET 1: 28 ATLANTIC AVE, SUITE 129 CITY: BOSTON STATE: MA ZIP: 02110 D 1 primary_doc.xml X0708 D LIVE 0001788222 Psy Therapeutics, Inc. 28 Atlantic Ave, Suite 129 Boston MA MASSACHUSETTS 02110 (617) 723-5429 DELAWARE PsyBrain, Inc. None Corporation true David S. Barlow c/o Psy Therapeutics, Inc. 28 Atlantic Ave, Suite 129 Boston MA MASSACHUSETTS 02110 Executive Officer Director Brant Binder c/o Psy Therapeutics, Inc. 28 Atlantic Ave, Suite 129 Boston MA MASSACHUSETTS 02110 Executive Officer Director Bryan Roberts c/o Psy Therapeutics, Inc. 28 Atlantic Ave, Suite 129 Boston MA MASSACHUSETTS 02110 Director Daniel Weiss Pick c/o Psy Therapeutics, Inc. 640 Lewis Wharf Boston MA MASSACHUSETTS 02110 Director Alan Cross c/o Psy Therapeutics, Inc. 28 Atlantic Ave, Suite 129 Boston MA MASSACHUSETTS 02110 Executive Officer Other Health Care Decline to Disclose 06b false 2019-09-23 false true false 0 4297692 3967692 330000 Amount sold includes $2,967,692 of principal and accrued interest on certain convertible promissory notes which were converted to equity. false 19 0 0 0 false Psy Therapeutics, Inc. /s/ David S. Barlow David S. Barlow Chief Executive Officer 2019-10-01